Jazz Pharmaceuticals Completes U.S. Divestiture Of Sunosi To Axsome Therapeutics, What's Next?
Jazz Pharma Reports Q1 Epidiolex Sales Increased 6% To $157.9M YoY
Court Dismisses Canopy's Cannabis Patent Infringement Lawsuit Against Jazz's GW Pharma
Jazz Pharmaceuticals Announces Full Year And 4Q 2021 Financial Results